We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$546M
AUM Growth
+$20.5M
Cap. Flow
+$5.52M
Cap. Flow %
1.01%
Top 10 Hldgs %
55.37%
Holding
35
New
6
Increased
12
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$27.4M
2
BAX icon
Baxter International
BAX
+$16.4M
3
CNC icon
Centene
CNC
+$9.56M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.49M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$7.43M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$16.7M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$15M
3
BSX icon
Boston Scientific
BSX
+$11.7M
4
GILD icon
Gilead Sciences
GILD
+$10.3M
5
LH icon
Labcorp
LH
+$6.15M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$143B
$49.5M 9.06%
1,365,763
+772,513
+130% +$27.4M
GILD icon
2
Gilead Sciences
GILD
$167B
$43.9M 8.03%
678,633
-159,507
-19% -$10.3M
MRK icon
3
Merck
MRK
$315B
$39M 7.15%
530,472
-75,493
-12% -$5.57M
INCY icon
4
Incyte
INCY
$23.4B
$27.7M 5.08%
341,051
-10,578
-3% -$903K
MDT icon
5
Medtronic
MDT
$106B
$27.1M 4.96%
229,323
-8,200
-3% -$961K
BDX icon
6
Becton Dickinson
BDX
$43.6B
$24.8M 4.53%
104,332
-20,559
-16% -$5.02M
BRKR icon
7
Bruker
BRKR
$8.86B
$24.3M 4.45%
377,767
+50,290
+15% +$3.02M
BMY icon
8
Bristol-Myers Squibb
BMY
$124B
$23.4M 4.29%
371,062
+9,719
+3% +$605K
CNC icon
9
Centene
CNC
$32.8B
$22.3M 4.08%
348,451
+154,439
+80% +$9.56M
IONS icon
10
Ionis Pharmaceuticals
IONS
$8.99B
$20.4M 3.74%
454,150
+133,158
+41% +$7.43M
ELV icon
11
Elevance Health
ELV
$80.9B
$20.4M 3.73%
56,771
+9,411
+20% +$3.03M
CAH icon
12
Cardinal Health
CAH
$53.5B
$19.7M 3.61%
324,464
+33,614
+12% +$1.86M
NUVA
13
DELISTED
NuVasive, Inc.
NUVA
$18.3M 3.35%
279,259
+23,899
+9% +$1.43M
CVS icon
14
CVS Health
CVS
$137B
$18M 3.3%
239,463
+3,645
+2% +$266K
BAX icon
15
Baxter International
BAX
$11.7B
$17.5M 3.2%
+206,951
New +$16.4M
RVTY icon
16
Revvity
RVTY
$12.3B
$15.1M 2.76%
117,467
-26,464
-18% -$3.67M
BSX icon
17
Boston Scientific
BSX
$65.4B
$14.7M 2.7%
381,536
-308,746
-45% -$11.7M
BIIB icon
18
Biogen
BIIB
$30.4B
$13.8M 2.52%
49,260
-16,325
-25% -$4.4M
ELAN icon
19
Elanco Animal Health
ELAN
$12.9B
$12.4M 2.27%
419,979
+51,688
+14% +$1.59M
LH icon
20
Labcorp
LH
$23.2B
$11.7M 2.14%
53,243
-30,639
-37% -$6.15M
BIO icon
21
Bio-Rad Laboratories Class A
BIO
$8.15B
$11.2M 2.05%
19,557
-1,860
-9% -$1.1M
LIVN icon
22
LivaNova
LIVN
$4.43B
$10.4M 1.91%
141,483
-59,747
-30% -$4.26M
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$35.7B
$8.44M 1.55%
59,789
+30,174
+102% +$4.54M
PRGO icon
24
Perrigo
PRGO
$1.48B
$8.29M 1.52%
204,878
+36,956
+22% +$1.59M
ALXN
25
DELISTED
Alexion Pharmaceuticals
ALXN
$7.75M 1.42%
50,657
-97,170
-66% -$15M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2021 Portfolio in Review

As of Q1 2021, Sector Gamma AS held 35 positions worth $546M, up 3.9% from $525M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Sector Gamma AS's Q1 2021 filing shows 6 new, 12 increased, 15 reduced and 2 closed positions. Its largest new stake was Baxter International: 206,951 shares worth $17.5M. The largest sale was Abbott, an estimated $16.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q1 2021 buy was Baxter International: 206,951 shares worth $17.5M.
  • Sector Gamma AS added most to Pfizer in Q1 2021, an estimated $27.4M increase.
  • Sector Gamma AS's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $15M.
  • Sector Gamma AS fully exited Abbott in Q1 2021, selling an estimated $16.7M.
  • Sector Gamma AS's ten largest holdings make up 55% of its $546M portfolio in Q1 2021.
  • Sector Gamma AS opened 6 new positions and closed 2 in Q1 2021.
  • Sector Gamma AS's portfolio value rose 3.9% quarter-over-quarter to $546M.

Based on Sector Gamma AS's 13F filing for Q1 2021, filed 10 May 2021.